This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder

Clinical trial NCT01972841 · COMPLETED

Trial details

NCT number: NCT01972841
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Urinary Bladder Overactive Urinary Bladder Diseases\Urologic Diseases Overactive Bladder Urgency Incontinence

Start date: 2013-11-05
Primary completion: 2015-10-22
Enrollment: 3527

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.